Literature DB >> 23454156

Trends in partial and radical nephrectomy: an analysis of case logs from certifying urologists.

Stephen A Poon1, Jonathan L Silberstein, Ling Y Chen, Behfar Ehdaie, Philip H Kim, Paul Russo.   

Abstract

PURPOSE: Surgical treatment options for renal masses include radical vs partial nephrectomy and the open vs laparoscopic approach. Using American Board of Urology (ABU) case log data, we investigated contemporary trends in these treatment options, and how surgeon and practice characteristics may influence these trends.
MATERIALS AND METHODS: Annualized case log data for nephrectomy were obtained from the ABU for all urologists certifying or recertifying from 2002 to 2010. We evaluated trends in nephrectomy use. Logistic regression was used to evaluate surgeon and practice characteristics as predictors of partial and laparoscopic procedures.
RESULTS: From the 3,852 case logs submitted by nonpediatric urologists we analyzed a total of 48,384 nephrectomies. From 2002 to 2010 the proportion of annual nephrectomies performed as open radical nephrectomy gradually decreased from 54% to 29%. During the same period, there was a moderate gradual increase in laparoscopic radical nephrectomies (from 30% to 39%). The proportion of open partial nephrectomies remained stable at 15%, while laparoscopic partial nephrectomy increased from 2% to 17%. On multivariable analysis the use of partial nephrectomy and laparoscopy was predicted by urologist annual nephrectomy volume, initial or recertification status, subspecialty, practice area size and geographic region.
CONCLUSIONS: Since 2002, the use of laparoscopic nephrectomy and partial nephrectomy has increased. However, the diffusion of these techniques is not uniform. Initial certification, higher surgical volume, and practicing in areas with more than 1,000,000 population and in the Northeast region were associated with greater use of laparoscopy and partial nephrectomy. Factors that affect the adoption of these techniques require further research.
Copyright © 2013 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  LPN; LRN; NSS; OPN; ORN; PN; RN; RP; kidney; kidney neoplasms; laparoscopic PN; laparoscopic RN; laparoscopy; nephrectomy; nephron sparing surgery; open PN; open RN; partial nephrectomy; physician's practice patterns; radical nephrectomy; radical prostatectomy

Mesh:

Year:  2013        PMID: 23454156      PMCID: PMC3710515          DOI: 10.1016/j.juro.2013.02.094

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  19 in total

1.  Who you are and where you live: how race and geography affect the treatment of medicare beneficiaries.

Authors:  Katherine Baicker; Amitabh Chandra; Jonathan S Skinner; John E Wennberg
Journal:  Health Aff (Millwood)       Date:  2004       Impact factor: 6.301

2.  Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study.

Authors:  William C Huang; Andrew S Levey; Angel M Serio; Mark Snyder; Andrew J Vickers; Ganesh V Raj; Peter T Scardino; Paul Russo
Journal:  Lancet Oncol       Date:  2006-09       Impact factor: 41.316

3.  Robotic-assisted laparoscopic prostatectomy: what is the learning curve?

Authors:  S Duke Herrell; Joseph A Smith
Journal:  Urology       Date:  2005-11       Impact factor: 2.649

4.  Trends in the diffusion of laparoscopic nephrectomy.

Authors:  David C Miller; John T Wei; Rodney L Dunn; Brent K Hollenbeck
Journal:  JAMA       Date:  2006-06-07       Impact factor: 56.272

5.  Laparoscopic nephrectomy: initial case report.

Authors:  R V Clayman; L R Kavoussi; N J Soper; S M Dierks; S Meretyk; M D Darcy; F D Roemer; E D Pingleton; P G Thomson; S R Long
Journal:  J Urol       Date:  1991-08       Impact factor: 7.450

6.  Laparoscopy for renal cell carcinoma: diffusion versus regionalization?

Authors:  David C Miller; David A Taub; Rodney L Dunn; John T Wei; Brent K Hollenbeck
Journal:  J Urol       Date:  2006-09       Impact factor: 7.450

7.  National utilization trends of partial nephrectomy for renal cell carcinoma: a case of underutilization?

Authors:  Brent K Hollenbeck; David A Taub; David C Miller; Rodney L Dunn; John T Wei
Journal:  Urology       Date:  2006-01-25       Impact factor: 2.649

8.  Contemporary open and robotic radical prostatectomy practice patterns among urologists in the United States.

Authors:  William T Lowrance; James A Eastham; Caroline Savage; A C Maschino; Vincent P Laudone; Christopher B Dechet; Robert A Stephenson; Peter T Scardino; Jaspreet S Sandhu
Journal:  J Urol       Date:  2012-04-11       Impact factor: 7.450

Review 9.  Renal cell carcinoma: presentation, staging, and surgical treatment.

Authors:  P Russo
Journal:  Semin Oncol       Date:  2000-04       Impact factor: 4.929

10.  Partial nephrectomy for small renal masses: an emerging quality of care concern?

Authors:  David C Miller; John M Hollingsworth; Khaled S Hafez; Stephanie Daignault; Brent K Hollenbeck
Journal:  J Urol       Date:  2006-03       Impact factor: 7.450

View more
  20 in total

1.  Postoperative drainage does not prevent complications after robotic partial nephrectomy.

Authors:  Benoit Peyronnet; Benjamin Pradère; Alexandre De La Taille; Franck Bruyère; Nicolas Doumerc; Stéphane Droupy; Christophe Vaessen; Hervé Baumert; Jean-Christophe Bernhard; Morgan Rouprêt; Arnaud Mejean; Karim Bensalah
Journal:  World J Urol       Date:  2015-10-28       Impact factor: 4.226

Review 2.  Novel Technologies in Urologic Surgery: a Rapidly Changing Scenario.

Authors:  Giorgio Gandaglia; Peter Schatteman; Geert De Naeyer; Frederiek D'Hondt; Alexandre Mottrie
Journal:  Curr Urol Rep       Date:  2016-03       Impact factor: 3.092

3.  Analysis of the impact of adherent perirenal fat on peri-operative outcomes of robotic partial nephrectomy.

Authors:  Zine-Eddine Khene; Benoit Peyronnet; Romain Mathieu; Tarek Fardoun; Grégory Verhoest; Karim Bensalah
Journal:  World J Urol       Date:  2015-02-11       Impact factor: 4.226

4.  [Minimum caseload requirements in urologic oncology: not without evidence from health services research].

Authors:  J Huber; C Groeben; M P Wirth; F Hoffmann
Journal:  Urologe A       Date:  2014-12       Impact factor: 0.639

5.  3D printed renal cancer models derived from MRI data: application in pre-surgical planning.

Authors:  Nicole Wake; Temitope Rude; Stella K Kang; Michael D Stifelman; James F Borin; Daniel K Sodickson; William C Huang; Hersh Chandarana
Journal:  Abdom Radiol (NY)       Date:  2017-05

Review 6.  Trends in surgical management of T1 renal cell carcinoma.

Authors:  Jonas Schiffmann; Marco Bianchi; Maxine Sun; Andreas Becker
Journal:  Curr Urol Rep       Date:  2014-02       Impact factor: 3.092

7.  Toward greater adoption of minimally invasive and nephron-sparing surgical techniques for renal cell cancer in the United States.

Authors:  Matthew P Banegas; Linda C Harlan; Bhupinder Mann; K Robin Yabroff
Journal:  Urol Oncol       Date:  2016-06-16       Impact factor: 3.498

Review 8.  Post partial nephrectomy surveillance imaging: an evidence-based approach.

Authors:  Lorenzo Marconi; Michael A Gorin; Mohamad E Allaf
Journal:  Curr Urol Rep       Date:  2015-04       Impact factor: 3.092

9.  Oncological outcomes of minimally invasive partial versus minimally invasive radical nephrectomy for cT1-2/N0/M0 clear cell renal cell carcinoma: a propensity score-matched analysis.

Authors:  Giuseppe Simone; Gabriele Tuderti; Umberto Anceschi; Rocco Papalia; Mariaconsiglia Ferriero; Leonardo Misuraca; Francesco Minisola; Riccardo Mastroianni; Manuela Costantini; Salvatore Guaglianone; Steno Sentinelli; Michele Gallucci
Journal:  World J Urol       Date:  2016-08-30       Impact factor: 4.226

10.  Follow the light: projector-based augmented reality intracorporeal system for laparoscopic surgery.

Authors:  Philip Edgcumbe; Rohit Singla; Philip Pratt; Caitlin Schneider; Christopher Nguan; Robert Rohling
Journal:  J Med Imaging (Bellingham)       Date:  2018-02-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.